Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine.
about
Immunogenicity of a promiscuous T cell epitope peptide based conjugate vaccine against benzo[a]pyrene: redirecting antibodies to the haptenEnhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of ageSyntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisationSynthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccinesMucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes.Monoclonal antibodies that recognize a common pneumococcal protein with similarities to streptococcal group A surface glyceraldehyde-3-phosphate dehydrogenaseSynthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Combination Vaccines.
P2860
Q28483992-7503B918-5AC8-4A41-9F93-72FAB363533FQ33597864-203D9B16-E8EE-41B5-AF27-7B5E9FA08B96Q33753799-AC2EAA29-D464-4C56-9238-AA636A905227Q33810465-8FC8AAB5-DA5B-4360-B16E-B1B2F3686EAFQ34002606-3216BF1B-DA5B-4569-B35B-253BDC22A29EQ34160588-12EF8B27-3087-4F2A-855A-45CE0AF5941BQ34531792-A57027FB-091A-441D-BB3F-B0DA93DD750CQ34799955-C396931E-8EDA-4C1D-9629-06D79ECBC64CQ35393344-F05F314F-4180-4614-AD1C-D24BC666F787Q35423315-7E62DE59-554A-424C-BFF2-352BDCE556FBQ35516062-5D7B2BBB-7C90-46B7-ADE5-0836E6B2395AQ37608314-F03C16CE-9D80-4AE2-A461-5D3A39C5A0B5Q40056277-79AECB05-9C5E-46B0-A2E2-9312CB4B30AEQ54857966-222B4608-DE66-4D0E-83B3-4295A646EE65
P2860
Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Opposite effects of actively a ...... nzae type b conjugate vaccine.
@ast
Opposite effects of actively a ...... nzae type b conjugate vaccine.
@en
type
label
Opposite effects of actively a ...... nzae type b conjugate vaccine.
@ast
Opposite effects of actively a ...... nzae type b conjugate vaccine.
@en
prefLabel
Opposite effects of actively a ...... nzae type b conjugate vaccine.
@ast
Opposite effects of actively a ...... nzae type b conjugate vaccine.
@en
P2093
P2860
P1476
Opposite effects of actively a ...... enzae type b conjugate vaccine
@en
P2093
P2860
P407
P577
1994-01-01T00:00:00Z